CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 77% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 77% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

YTD highs for US stocks; GE soars

17:26 25 February 2019

Summary:

  • US benchmarks rally to 2019 peak

  • Latest gains driven by trade hopes

  • GE shares soar on deal to sell biopharma business

 

News over the weekend that the US will delay increasing tariffs on $200B of Chinese imports has provided more fuel to the rally seen in US stocks, with all 4 benchmarks on xStation hitting their highest level of the year this afternoon. As is often the case, the US100 is the best performing and higher by 0.84% at the time of writing.

Start investing today or test a free demo

Open account Try demo Download mobile app Download mobile app

There’s a sea of green amongst US indices this afternoon with the US100 the best performer and adding over 0.8% to trade back above 7150. Source: xStation

 

The US100 has moved up to its highest level since early November today with price attempting to break out above previous resistance around the 7100 level. Quite surprisingly given the strong gains in recent weeks, the RSI is still not in overbought territory - as defined by above the 70 mark. There could be some resistance overhead around the 7210 mark which has previously acted as something of a swing level, but for the time being the uptrend that began at the back end of 2018 remains firmly intact.

Despite the strong gains the US100 is still short of overbought territory according to the RSI on D1, which at 68.3 is still beneath the 70 mark. Source: xStation  

 

Looking at individual shares in the US, General Electric (GE) is enjoying a strong push higher after the firm announced a deal to sell its biopharma business. Danaher Group are reportedly paying $21 billion for the business and will also assume certain pension liabilities. Wall Street analysts covering GE said the deal should help alleviate much of the liquidity concerns around the company and the market reaction has been clearly positive with the stock jumping over 10% on the open and trading higher by almost 9% at the time of writing.

GE shares have jumped higher on the news, but the longer-term downtrend remains in tact for now with price still not even at the 23.6% fib at 12.93 of the larger declines seen in recent years. Source: xStation

 

 

This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.

Back
Xtb logo

Join over 1 Million investors from around the world

We use cookies

By clicking “Accept All”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

This group contains cookies that are necessary for our websites to work. They take part in functionalities like language preferences, traffic distribution or keeping user session. They cannot be disabled.

Cookie name
Description
SERVERID
userBranchSymbol cc 2 March 2024
adobe_unique_id cc 1 March 2025
test_cookie cc 1 March 2024
SESSID cc 9 September 2022
__hssc cc 1 March 2024
__cf_bm cc 1 March 2024
intercom-id-iojaybix cc 26 November 2024
intercom-session-iojaybix cc 8 March 2024

We use tools that let us analyze the usage of our page. Such data lets us improve the user experience of our web service.

Cookie name
Description
_gid cc 9 September 2022
_gat_UA-22576382-1 cc 8 September 2022
_gat_UA-121192761-1 cc 8 September 2022
_ga_CBPL72L2EC cc 1 March 2026
_ga cc 1 March 2026
AnalyticsSyncHistory cc 8 October 2022
af_id cc 31 March 2025
afUserId cc 1 March 2026
af_id cc 1 March 2026
AF_SYNC cc 8 March 2024
__hstc cc 28 August 2024
__hssrc

This group of cookies is used to show you ads of topics that you are interested in. It also lets us monitor our marketing activities, it helps to measure the performance of our ads.

Cookie name
Description
MUID cc 26 March 2025
_omappvp cc 11 February 2035
_omappvs cc 1 March 2024
_uetsid cc 2 March 2024
_uetvid cc 26 March 2025
_fbp cc 30 May 2024
fr cc 7 December 2022
muc_ads cc 7 September 2024
lang
_ttp cc 26 March 2025
_tt_enable_cookie cc 26 March 2025
_ttp cc 26 March 2025
hubspotutk cc 28 August 2024

Cookies from this group store your preferences you gave while using the site, so that they will already be here when you visit the page after some time.

Cookie name
Description
personalization_id cc 7 September 2024
UserMatchHistory cc 8 October 2022
bcookie cc 8 September 2023
lidc cc 9 September 2022
lang
bscookie cc 8 September 2023
li_gc cc 7 March 2023

This page uses cookies. Cookies are files stored in your browser and are used by most websites to help personalise your web experience. For more information see our Privacy Policy You can manage cookies by clicking "Settings". If you agree to our use of cookies, click "Accept all".

Change region and language
Country of residence
Language